Category: Clinical Considerations
MRI Reveals Significant Brain Abnormalities Post-COVID
(Neuroscience) Using a special type of MRI, researchers have uncovered brain changes in patients up to six months after they recovered from COVID-19, according to a study being presented next week at the annual meeting of the Radiological Society of North America (RSNA). About one in five adults will develop long-term effects from COVID-19, according to the […]
Nov 21, 2022
Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis: A Retrospective Cohort Study
(Neurology) The relationship between COVID-19 and epilepsy is uncertain. We studied the potential association between COVID-19 and seizures or epilepsy in the six months after infection. We applied validated methods to an electronic health records network (TriNetX Analytics) of 81 million people. We closely matched people with COVID-19 infections to those with influenza. In each […]
Nov 18, 2022
Omicron BA.2 tied to more symptoms and, rarely, brain swelling in kids
(CIDRAP) A UK study suggests that Omicron BA.2 is tied to more symptoms and greater disruption in daily activities than BA.1, and Taiwanese researchers describe fatal cerebral edema in six children hospitalized for BA.2. Imperial College London researchers tracked SARS-CoV-2 transmission and symptoms among 1,542,510 randomly selected English adults, including 17,448 COVID-19 patients, from May 1, 2020, […]
Nov 15, 2022
Acute and postacute sequelae associated with SARS-CoV-2 reinfection
(Nature) First infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with increased risk of acute and postacute death and sequelae in various organ systems. Whether reinfection adds to risks incurred after first infection is unclear. Here we used the US Department of Veterans Affairs’ national healthcare database to build a cohort of […]
Nov 11, 2022
How a SARS-CoV-2 virus protein damages the heart?
(Tech Expert) Scientists at the University of Maryland School of Medicine’s (UMSOM) Center for Precision Disease Modeling identified how SARS-CoV-2 damages heart tissue. Last year, in research involving fruit flies and human cells, the most lethal SARS-CoV-2 proteins were discovered. They found a promising drug selinexor reduced the toxicity of one of these proteins but not the […]
Nov 8, 2022
Researchers create new model to detect COVID’s effects using chest X-rays
(Iowa Now) For patients dealing with lingering respiratory symptoms from the novel coronavirus, a chest X-ray can reveal only so much. The two-dimensional (2D) scans simply can’t distinguish compromised lung function. For that diagnosis, a more expensive, three-dimensional (3D) technique called a CT scan is necessary. Yet many medical clinics in the United States don’t have […]
Nov 1, 2022
Covid-19 Infection Linked With Poor Cardiovascular Outcomes And Death
(Forbes) A new UK study shows that being infected with Covid-19 is linked to an increased risk of poor cardiovascular health and death. The risk is greatest within the first 30 days of infection and for those whose infection required hospitalization, but the risk also remains heightened for those who did not experience a severe infection. When […]
Nov 1, 2022
‘A silent killer’ – COVID-19 shown to trigger inflammation in the brain
(University of Queensland) Research led by The University of Queensland has found COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease. The discovery identified a potential future risk for neurodegenerative conditions in people who’ve had COVID-19, but also a possible treatment. The UQ team was led by Professor Trent Woodruff and Dr Eduardo Albornoz Balmaceda from UQ’s School […]
Nov 1, 2022
HIV Coinfection in Over 80% of Hospitalized Monkeypox Cases
(MedPageToday) In a cohort of patients hospitalized for monkeypox, four out of five had HIV and one in five died, CDC researchers said. Of the 57 adults hospitalized due to serious complications from monkeypox, 82.5% had HIV and 8.5% were receiving antiretroviral therapy, reported Maureen Miller, MD, of the CDC’s Monkeypox Emergency Response Team, and […]
Oct 28, 2022
Neurologic, neurocognitive symptoms of COVID-19 persist for 1 year after diagnosis
(Healio Neurology) Persistent neurocognitive impairment, depression and anxiety were frequently reported in individuals with mild COVID-19 infection in Lima, Peru, according to a poster at ANA 2022. “Given the fact that this population has a different background, different culture and socioeconomic status, the outcomes aren’t necessarily going to be the same as those from high-income […]
Oct 27, 2022